The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Glucagon-like peptide-1 7–36: a physiological incretin in man
Abstract
The physiological role of glucagon-like peptide-1 7-36 amide (GLP-1 7-36) in man was investigated. GLP-1 7-36-like immunoreactivity was found in the human bowel; its circulating level rose after oral glucose and after a test breakfast. When it was infused into seven volunteers at a rate to mimic its postprandial plasma concentration in the fasting state, plasma insulin levels rose significantly and glucose and glucagon concentrations fell. During an intravenous glucose load, it greatly enhanced insulin release and significantly reduced peak plasma glucose concentrations, compared with a control saline infusion, even inducing postinfusion reactive hypoglycaemia. By comparison, infusion of glucose-dependent insulinotropic peptide (GIP) to physiological levels was less effective in stimulating insulin release. These observations suggest that GLP-1 7-36 is a physiological incretin and that it is more powerful than GIP. The observation of greatly increased postprandial plasma GLP-1 7-36 levels in patients with postgastrectomy dumping syndrome suggests that it may mediate the hyperinsulinaemia and reactive hypoglycaemia of this disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, in vivo, GIP was shown to promote lipolysis under conditions of normo- or hypoinsulinemia, and mice overexpressing GIP exhibit lower fat mass when fed a high-fat diet41.”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [41]
In the citing paper
“With respect to GIPR agonism, while a definitive mechanism in how GIPR signaling impacts energy balance is yet to be reported, GIPR activation has been associated with improved adipose tissue health41,106,123,171.”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [41]
In the citing paper
“This effect describes the observation that orally, but not intravenously, administered glucose enhances insulin secretion by triggering GLP-1 and GIP secretion;73, 74, 75 the resulting potentiation of insulin secretion may account for up to 50% of the total release.”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [75]
In the citing paper
“GLP-1 RA increase satiety, reduce food intake and delay gastric emptying whilst they also stimulate insulin release and inhibit glucagon secretion in a glucose-dependent manner (Fig. 1) [17, 18].”
From What is the pipeline for future medications for obesity? (2025) · cites this paper as [18]
In the citing paper
“The major effect of incretins is the potentiation of glucose-stimulated insulin secretion by pancreatic β-cells [14,15,16,17].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [15]
Citations
Cites
Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity
HUNTER, W. M., & GREENWOOD, F. C. (1962) · Nature · doi:10.1038/194495a0 · Cited by 6,919
Mojsov, S., Weir, G. C., & Habener, J. F. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112855 · Cited by 882
STIMULATION OF INSULIN SECRETION BY GASTRIC INHIBITORY POLYPEPTIDE IN MAN. 1
Dupre, J., Ross, S. A., Watson, D., & Brown, J. C. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-37-5-826 · Cited by 860
Antibodies to Bradykinin and Angiotensin: A Use of Carbodiimides in Immunology
Goodfriend, T. L., Levine, L., & Fasman, G. D. (1964) · Science · doi:10.1126/science.144.3624.1344 · Cited by 807
Mojsov, S., Heinrich, G., Wilson, I. B., Ravazzola, M., Orci, L., & Habener, J. F. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67324-7 · Cited by 724
Albano, J. D. M., Ekins, R. P., Maritz, G., & Turner, R. C. (1972) · Acta Endocrinologica · doi:10.1530/acta.0.0700487 · Cited by 620
Truncated glucagon‐like peptide I, an insulin‐releasing hormone from the distal gut
Holst, J. J., Ørskov, C., Vagn Nielsen, O., & Schwartz, T. W. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)81430-8 · Cited by 615
Exon duplication and divergence in the human preproglucagon gene
Bell, G. I., Sanchez-Pescador, R., Laybourn, P. J., & Najarian, R. C. (1983) · Nature · doi:10.1038/304368a0 · Cited by 593
Schmidt, W. E., Siegel, E. G., & Creutzfeldt, W. (1985) · Diabetologia · doi:10.1007/bf00291980 · Cited by 319
Baron, A. D., Schaeffer, L., Shragg, P., & Kolterman, O. G. (1987) · Diabetes · doi:10.2337/diab.36.3.274 · Cited by 308
Research works printed but not linked: 1
- Zunz, 1929, Contributions a l'étude des variations physiologique de la secretion interne du pancreas, Arth Int Physiol Biochem, 31, 20
Cited by
Biology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
The biology of incretin hormones
Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210
Glucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868
Self-citationEpidemiology of Diabetes and Diabetes-Related Complications
Deshpande, A. D., Harris-Hayes, M., & Schootman, M. (2008) · Physical Therapy · doi:10.2522/ptj.20080020 · Cited by 1,773
Metadata
- Authors
- Kreymann, B., Ghatei, M. A., Williams, G., & Bloom, S. R.
- Affiliations
- Hammersmith Hospital (GB)
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1987-12
- Volume
- 330
- Issue
- 8571
- Pages
- 1300-1304
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2080128749
- Cited by
- 1,928
- References
- 29
- Citations by year
- 2026: 55 · 2025: 61 · 2024: 64 · 2023: 46 · 2022: 42 · 2021: 52 · 2020: 54 · 2019: 56 · 2018: 61 · 2017: 57 · 2016: 70 · 2015: 78 · 2014: 83 · 2013: 93 · 2012: 69
- FWCI
- 24.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- incretins, glucose-dependent insulinotropic polypeptide, insulin secretion, postprandial blood glucose, reactive hypoglycaemia, hyperinsulinemia, gut hormone secretion, glucagon, oral glucose tolerance
- MeSH terms
- Adult, Aged, Blood Glucose, Eating, Gastric Inhibitory Polypeptide, Glucose, Humans, Insulin, Male, Middle Aged, Peptides, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glucagon-like peptide-1 7–36: a physiological incretin in man. https://app.cochat.ai/papers/10.1016/s0140-6736(87)91194-9
- The paper
- Kreymann, B., Ghatei, M. A., Williams, G., & Bloom, S. R. (1987). Glucagon-like peptide-1 7–36: a physiological incretin in man. The Lancet. https://doi.org/10.1016/s0140-6736(87)91194-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.